The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 45% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 142%. Our forward projection puts the odds of a 10% gain over the next month near 31%.
Himalaya Shipping Ltd.
HSHP · the NYSE · USD · Market cap $664M
FAIL · Does not pass the screenAt the last full screen
2026-05-22
Screened 2026-05-22 · the tape above runs as of 22:12 UTC · 11 Sep · two dates, stated on purpose · verdict and workings shown in full · never trimmed
This name holds its accumulation label.
Himalaya Shipping Ltd. holds its Accumulation at $14.63. Consolidating, no directional conviction, held for 12 days.
| Phase | Accumulation |
| Quantitative state | Consolidating, no directional conviction, held for 12 days |
| Price at the screen | $14.63 |
| Valuation | 22.45 trailing · 0.00 forward price to earnings |
| Values screen | FAIL |
Five Screens, Shown in Full
Does not pass. Debt ratio
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 102.85% | Below 33% | Interest-bearing debt is 102.8% of its assets, above the one-third ceiling the screen allows. | Fail |
| Interest-bearing cash | 3.69% | Below 33% | Cash held in interest-bearing accounts and securities is 3.7% of assets, under the one-third limit. | Pass |
| Receivables | 0.00% | Below 49% | Money owed to the company is 0.0% of assets, under the 49% limit. | Pass |
| Revenue purity | 0.00% | Below 5% | Only 0.0% of revenue comes from non-compliant sources, under the 5% line. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Business, in Plain Words| Forward P/E | 0.0x |
| Trailing P/E | 22.4xa premium valuation |
| EPS, trailing | 0.63 |
| EPS, forward | 0.00 |
| Revenue growth | +52.9%growing very fast |
| Profit margin | 20.3%healthy profit margins |
| Return on equity | 18.3%a solid return on shareholder capital |
| Dividend yield | 628.00% |
| Debt to equity | 4.39heavy leverage: higher risk if revenue softens |
| Market cap | $664M |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeHSHP trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 45% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 142%. Our forward projection puts the odds of a 10% gain over the next month near 31%.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 45% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 142%. Our forward projection puts the odds of a 10% gain over the next month near 31%.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
The framework reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $15.78 | -7.1% | $0.15 | $939 | -6.1% |
| 2 months | $13.30 | +10.2% | $0.21 | $1,118 | +11.8% |
| 3 months | $12.60 | +16.3% | $0.27 | $1,185 | +18.5% |
| 6 months | $8.90 | +64.7% | $0.33 | $1,684 | +68.4% |
| 1 year | $6.05 | +142.2% | $0.41 | $2,490 | +149.0% |
| 2 years | $8.25 | +77.8% | $0.86 | $1,881 | +88.1% |
| 3 years | $4.99 | +193.8% | $0.97 | $3,131 | +213.1% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever HSHP does next, these words stay.
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.